| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21b5b8c86cc80bb79fefd52ea6762524 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-00 |
| filingDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9726fa7a215b647a100fba903cb915bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81348e257ea1dc8b70c28a4e38d9613d |
| publicationDate |
2011-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2010010390-A |
| titleOfInvention |
USE OF FERRITINE TO TREAT IRON DEFICIENCY DISORDERS. |
| abstract |
H-ferritin receptors in endothelial cells. In rat brain, brain microvasculature there is a means to transport iron through the blood brain barrier. A method of treating an iron deficiency disorder in the brain in a patient comprises administering an H-ferritin-iron complex to a patient in need. One method of using H-ferritin as a steering fraction comprises fixing H-ferritin to a liposome directed to the brain or cells within the brain. One method of treating an iron overload disorder in a patient comprises administering to a patient a multi-subunit ferritin complex at less than 100% iron binding capacity. |
| priorityDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |